{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:51:06Z","timestamp":1761490266344,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1807-y","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T15:57:28Z","timestamp":1493049448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies"],"prefix":"10.1186","volume":"16","author":[{"name":"ACTwatch Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sochea","family":"Phok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dysoley","family":"Lek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"1807_CR1","unstructured":"CNM. Malaria elimination action framework 2016\u20132020. PhnomPenh: Malaria Eradication Scientific Alliance Website; 2016. \n                    http:\/\/www.malariaeradication.org\/knowledge-hub\/cambodia-malaria-elimination-action-framework-2016-2020\n                    \n                  . Accessed 29 Mar 2017."},{"key":"1807_CR2","unstructured":"WHO. World Malaria Report. Geneva: World Health Organization; 2016. World Health Organization Website. \n                    http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/report\/en\/\n                    \n                  . Accessed 3 April 2017. ."},{"key":"1807_CR3","unstructured":"CNM. Annual Malaria Report 2016."},{"key":"1807_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1475-2875-10-328","volume":"10","author":"M Littrell","year":"2011","unstructured":"Littrell M, Gatakaa H, Phok S, Allen H, Yeung S, Chuor CM, et al. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys. Malar J. 2011;10:328.","journal-title":"Malar J."},{"key":"1807_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12936-016-1200-2","volume":"15","author":"J Novotny","year":"2016","unstructured":"ACTwatch Group, Novotny J, Singh A, Dysoley L, Sovannaroth S, Rekol H. Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys. Malar J. 2016;15:194.","journal-title":"Malar J."},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1475-2875-10-243","volume":"10","author":"S Yeung","year":"2011","unstructured":"Yeung S, Patouillard E, Allen H, Socheat D. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia. Malar J. 2011;10:243.","journal-title":"Malar J."},{"key":"1807_CR7","unstructured":"Sokea V. Important regulatory steps being taken in Cambodia to phase out oral artemisinin-based monotherapies. World Health Organization Website. 2010. \n                    http:\/\/www.who.int\/medicines\/areas\/quality_safety\/regulation_legislation\/icdra\/PL6-3.pdf\n                    \n                  . Accessed 2 April 2017 ."},{"key":"1807_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1475-2875-10-326","volume":"10","author":"KA O\u2019Connell","year":"2011","unstructured":"O\u2019Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, et al. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J. 2011;10:326.","journal-title":"Malar J."},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1475-2875-10-325","volume":"10","author":"T Shewchuk","year":"2011","unstructured":"Shewchuk T, O\u2019Connell KA, Goodman C, Hanson K, Chapman S, Chavasse D. The ACTwatch project: methods to describe anti-malarial markets in seven countries. Malar J. 2011;10:325.","journal-title":"Malar J."},{"key":"1807_CR10","unstructured":"WHO\/GMP. Status Report on Artemisinin and ACT Resistance. Geneva: World Health Organization; 2015. World Health Organization Website. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/250294\/1\/WHO-HTM-GMP-2016.11-eng.pdf\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR11","unstructured":"WHO. Development of a strategy towards elimination of Plasmodium falciparum parasites with altered response to artemisinins. Bangkok: Report of an informal consultation; 2008. Malaria Consortium Website. \n                    http:\/\/www.malariaconsortium.org\/userfiles\/file\/Resistance-Resources\/Summary%20of%20Migrants%20Workshop%20(8-10%20June%202009).pdf\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR12","unstructured":"WHO. Emergency response to artemisinin resistance in the Greater Mekong subregion: regional framework for action 2013\u20132015. Geneva: World Health Organization; 2013. World Health Organization Website. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/79940\/1\/9789241505321_eng.pdf\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR13","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edn. Geneva: World Health Organization; 2015. World Health Organization Website. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/162441\/1\/9789241549127_eng.pdf\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR14","unstructured":"USAID-PMI. President\u2019s Malaria Initiative, Greater Mekong Sub-region, Malaria Operational Plan FY 2016. Washington, DC, USA, 2016. Presidents Malaria Initiative. \n                    https:\/\/www.pmi.gov\/docs\/default-source\/default-document-library\/malaria-operational-plans\/fy16\/fy-2016-greater-mekong-subregion-malaria-operational-plan.pdf?sfvrsn=4\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1475-2875-13-181","volume":"13","author":"I Mikkelsen-Lopez","year":"2014","unstructured":"Mikkelsen-Lopez I, Shango W, Barrington J, Ziegler R, Smith T, deSavigny D. The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania. Malar J. 2014;13:181.","journal-title":"Malar J."},{"key":"1807_CR16","unstructured":"Malaria Consortium. Project Brief: Private sector SMS referral system pilot. London: Malaria Consortium Webiste; 2013. \n                    http:\/\/www.malariaconsortium.org\/media-downloads\/229\/Private%20sector%20SMS%20referral%20system%20pilot\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12936-016-1292-8","volume":"15","author":"HS Khin","year":"2016","unstructured":"Khin HS, Aung T, Thi A, White C, ACTwatch Group. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014. Malar J. 2016;15:286.","journal-title":"Malar J."},{"key":"1807_CR18","unstructured":"ACTwatch Group. ACTwatch Study Reference Document: Lao PDR Outlet Survey 2015. Washington, DC. 2016. ACTwatch Group Website. \n                    http:\/\/www.actwatch.info\/sites\/default\/files\/content\/publications\/attachments\/Laos%202015%20Reference%20Document.pdf\n                    \n                  . Accessed 28 Mar 2017."},{"key":"1807_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1475-2875-9-109","volume":"9","author":"J Yasuoka","year":"2010","unstructured":"Yasuoka J, Poudel KC, Poudel-Tandukar K, Nguon C, Ly P, Socheat D, et al. Assessing the quality of service of village malaria workers to strengthen community-based malaria control in Cambodia. Malar J. 2010;9:109.","journal-title":"Malar J."},{"issue":"6 Suppl","key":"1807_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.77.203","volume":"77","author":"C Goodman","year":"2007","unstructured":"Goodman C, Brieger W, Unwin A, Mills A, Meek S, Greer G. Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg. 2007;77(6 Suppl):203\u201318.","journal-title":"Am J Trop Med Hyg"},{"key":"1807_CR21","unstructured":"WHO. Scaling up home-based management of malaria: from research to implementation.. Geneva: World Health Organization; 2004. World Health Organization Website. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/42918\/1\/WHO_HTM_MAL_2004.1096.pdf\n                    \n                  . Accessed 29 Mar 2017."},{"key":"1807_CR22","unstructured":"WHO. The Roll Back Malaria strategy for improving access to treatment through home management. Geneva: World Health Organization; 2005. World Health Organization Website. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/69057\/1\/WHO_HTM_MAL_2005.1101.pdf\n                    \n                  . Accessed 29 Mar 2017."},{"key":"1807_CR23","unstructured":"USAID. National strategy for utilizing the potential of private practitioners in child survival. Washington, DC, 2002. United States Agency for International Development. \n                    http:\/\/pdf.usaid.gov\/pdf_docs\/Pnacp202.pdf\n                    \n                  . Accessed 29 Mar 2017."},{"key":"1807_CR24","doi-asserted-by":"crossref","unstructured":"Tougher S, ACTwatch Group, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, et al. Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012;380:1916\u201326.","DOI":"10.1016\/S0140-6736(12)61732-2"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12936-015-0621-7","volume":"14","author":"T Aung","year":"2015","unstructured":"Aung T, White C, Montagu D, McFarland W, Hlaing T, Khin HS, et al. Improving uptake and use of malaria rapid diagnostic tests in the context of artemisinin drug resistance containment in eastern Myanmar: an evaluation of incentive schemes among informal private healthcare providers. Malar J. 2015;14:105.","journal-title":"Malar J."},{"key":"1807_CR26","first-page":"12","volume":"5","author":"S Sharma","year":"2015","unstructured":"Sharma S, Chaudhury RR. Improving availability and accessibility of medicines: a tool for increasing healthcare coverage. Arch Med. 2015;5:12.","journal-title":"Arch Med."},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12936-015-0896-8","volume":"14","author":"B Ley","year":"2015","unstructured":"Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malar J. 2015;14:377.","journal-title":"Malar J."},{"key":"1807_CR28","unstructured":"WHO. Policy brief on single-dose primaquine as a gametocytocide in Plasmodium falciparum malaria. Geneva: World Health Organization; 2005. World Health Organization Website. \n                    http:\/\/www.who.int\/malaria\/publications\/atoz\/who_htm_gmp_2015.1.pdf\n                    \n                  . Accessed 29 Mar 2017."},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"e0151898","DOI":"10.1371\/journal.pone.0151898","volume":"11","author":"G Bancone","year":"2016","unstructured":"Bancone G, Chowwiwat N, Somsakchaicharoen R, Poodpanya L, Moo PK, Gornsawun G, et al. Single low dose primaquine (0.25\u00a0mg\/kg) does not cause clinically significant haemolysis in G6PD deficient subjects. PLoS ONE. 2016;11:e0151898.","journal-title":"PLoS ONE"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12936-016-1341-3","volume":"15","author":"R Mwaiswelo","year":"2016","unstructured":"Mwaiswelo R, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, et al. Safety of a single low-dose of primaquine in addition to standard artemether\u2013lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania. Malar J. 2016;15:316.","journal-title":"Malar J."},{"key":"1807_CR31","unstructured":"ACTwatch Group. Malaria Market Trends in Sub-Saharan Africa: 2009\u20132014. Washington, D.C. 2016. ACTwatch Group Website. \n                    http:\/\/www.actwatch.info\/sites\/default\/files\/content\/publications\/attachments\/SSA%20Brief_FINAL_NO_BLEEDS.pdf\n                    \n                  . Accessed 3 April 2017."},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1475-2875-12-52","volume":"12","author":"KA O\u2019Connell","year":"2013","unstructured":"O\u2019Connell KA, Poyer S, Solomon T, Munroe E, Patouillard E, Njogu J, et al. Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J. 2013;12:52.","journal-title":"Malar J."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-017-1807-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:38:39Z","timestamp":1589528319000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1807-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1807-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2017,4,25]]},"assertion":[{"value":"5 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"171"}}